 Flunarizine Hydrochloride CAS:30484-77-6, CP EP (Offer to Sell)
Trade Lead Description:
Flunarizine is a drug classified as a calcium channel blocker. Flunarizine is a non-selective calcium entry blocker with COMBOLMIN binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. It may help to reduce the severity and duration of attacks of paralysis associated with the more serious form of alternating hemiplegia. Flunarizine has been shown to significantly reduce headache frequency and severity in both adults and children. Flunarizine has some side effects including weight gain, extrapyramidal effects, drowsiness and depression, it is contraindicated in hypotension, heart failure and arrhythmia. Flunarizine use is avoided in patients with depression, severe constipation or those with extrapyramidal disorders. Flunarizine was discovered at Janssen Pharmaceutica in 1968.
| Type of Offer: |
Offer to Sell |
| Quantity: |
Not Specified |
| Packaging: |
25KG |
| Price / Incoterms Conditions: |
CIF, EXW, FOB |
Posted from China - Guangdong on 28 August, 2013
|
|
